Drug intelligence / Profile preview

Biomodulina T + conventional therapy

Development stage: Unknown
Lead developer: BioCen
Modality: Peptides
Administration: Intramuscular, Intravenous

Overview

Biomodulina T is a biological immunomodulator developed by the Centro Nacional de Biopreparados (BioCen) in Cuba. It is a bovine thymic extract composed of specific polypeptide fractions designed to restore and modulate immune function. The drug primarily acts by stimulating the production of T lymphocytes and enhancing the differentiation of lymphoblastoid cells within the thymus. In the context of pediatric septic shock, Biomodulina T is administered as an adjunctive treatment alongside conventional therapy to counteract immunoparalysis and restore immune homeostasis. Beyond septic shock, it is also utilized or investigated for conditions such as chronic kidney disease (stage 5, hemodialysis), recurrent respiratory infections in the elderly, and post-chemotherapy immunorestitution in oncology.

Other names: thymic polypeptide extractBMT + conventional therapy

Beyond the preview

Go deeper on Biomodulina T + conventional therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomodulina T + conventional therapy.

Explore the full profile